Sarna

Charles River to support Belgian firm in manufacturing of saRNA vaccine

23-Jun-2022 By Jane Byrne

Charles River Labs is to manufacture and deliver an early-stage clinical supply of plasmid DNA for drug substance manufacturing to Ziphius Vaccines.

AstraZeneca invests in saRNA specialist

23-Sep-2021 By Jane Byrne

AstraZeneca has announced a long-term research collaboration with VaxEquity for the discovery, development and commercialization of its self-amplifying RNA (saRNA) therapeutics platform.

Lilly makes equity investment in saRNA tech company MiNA Therapeutics

06-Jul-2021 By Rachel Arthur

Eli Lilly and Company will make an equity investment of around $15m in MiNA Therapeutics: a company with a proprietary small activating RNA (saRNA) technology platform.

Eli Lilly and MiNA Therapeutics team up to develop saRNA tech

11-May-2021 By Rachel Arthur

Eli Lilly and Company and MiNA Therapeutics Ltd have announced a global research collaboration to develop novel drug candidates using MiNA’s proprietary small activating RNA (saRNA) technology platform.